横浜市立大学大学院 医学研究科 幹細胞免疫制御内科学血液・リウマチ・感染症内科

MENU

業績

2021年

感染症グループ

原著論文: 症例報告を含む

  1. Ebina-Shibuya R,Namkoong H,Horita N,Kato H,Hara Y,Kobayashi N,Kaneko T. Hydroxychloroquine and chloroquine for treatment of coronavirus disease 19 (COVID-19): a systematic review and meta-analysis of randomized and non-randomized controlled trials. J Thorac Dis,13(1):202-12.2021.
  2. Goto A,Go H,Miyakawa K,Yamaoka Y,Ohtake N,Kubo S,Sundararaj JS,Mihara T,Senuki K,Miyazaki T,Ikeda S,Ogura T,Kato H,Matsuba I,Sanno N,Miyakawa M,Ozaki H,Kikuoka M,Ohashi Y,Ryo A,Yamanaka T. Sustained neutralizing antibodies 6 months following infection in 376 Japanese COVID-19 survivors. Frontiers in Microbiology,12:661187. 2021.
  3. Horita N,Kato H,Watanabe K,Hara Y,Kobayashi N,Kaneko T. Declined mortality due to seasonal influenza in Japan during the coronavirus disease 2019 pandemic. Clin Infect Dis,ciab922. doi: 10.1093/cid/ciab922.2021.
  4. Ide K,Asami T,Suda A,Yoshimi A,Fujita J,Nomoto M,Roppongi T,Hino K,Takahashi Y,Watanabe K,Shimada T,Hamasaki T,Endo E,Kaneko T,Suzuki M,Kubota K,Saigusa Y,Kato H,Odawara T,Nakajima H,Takeuchi I,Goto T,Aihara M,Hishimoto A. The psychological effects of COVID-19 on hospital workers at the beginning of the outbreak with a large disease cluster on the Diamond Princess cruise ship. PLoS One,16(1):e0245294.2021.
  5. Imai M,Halfmann PJ,Yamayoshi S,Iwatsuki-Horimoto K,Chiba S,Watanabe T,Nakajima N,Ito M,Kuroda M,Kiso M,Maemura T,Takahashi K,Loeber S,Hatta M,Koga M,Nagai H,Yamamoto S,Saito M,Adachi E,Akasaka O,Nakamura M,Nakachi I,Ogura T,Baba R,Fujita K,Ochi J,Mitamura K,Kato H,Nakajima H,Yagi K,Hattori SI,Maeda K,Suzuki T,Miyazato Y,Valdez R,Gherasim C,Furusawa Y,Okuda M,Ujie M,Lopes TJS,Yasuhara A,Ueki H,Sakai-Tagawa Y,Eisfeld AJ,Baczenas JJ,Baker DA,O’Connor SL,O’Connor DH,Fukushi S,Fujimoto T,Kuroda Y,Gordon A,Maeda K,Ohmagari N,Sugaya N,Yotsuyanagi H,Mitsuya H,Suzuki T,Kawaoka Y. Characterization of a new SARS-CoV-2 variant that emerged in Brazil. Proc Natl Acad Sci U S A,118(27):e2106535118.2021.
  6. Kato H,Ohya T,Arai Y,Nakagawa K. Visualisation of droplet spread produced by a nebuliser during the COVID-19 pandemic. QJM,114(9): 623–624.2021.
  7. Kato H,Takeda R,Ideno Y,Suzuki T,Sano K,Nakamura K. Physicians’ compliance for hand hygiene in medical outpatient clinics: automated hand-hygiene monitoring with touch sensor and wireless internet. Am J Infect Control,49(1):50-54.2021.
  8. Miyakawa K,Kubo S,Stanleyraj Jeremiah S,Go H,Yamaoka Y,Ohtake N,Kato H,Ikeda S,Mihara T,Matsuba I,Sanno N,Miyakawa M,Shinkai M,Miyazaki T,Ogura T,Ito S,Kaneko T,Yamamoto K,Goto A,Ryo A. Persistence of Robust Humoral Immune Response in Coronavirus Disease 2019 Convalescent Individuals Over 12 Months After Infection. Open Forum Infect Dis,9(2):ofab626,2021.
  9. Miyakawa K,Stanleyraj JS,Kato H,Yamaoka Y,Go H,Yajima S,Shimada T,Mihara T,Goto A,Yamanaka T,Ryo A. Rapid detection of neutralizing antibodies to SARS-CoV-2 variants in post-vaccination sera. J Mol Cell Biol,mjab050,2021.
  10. Miyake S,Higurashi T,Kato H,Yamaoka Y,Kessoku T,Kato S,Ogawa F,Oi Y,Nakajima A,Yamamoto T,Takeuchi I,Ryo A,Maeda S. Evaluation of a combination protocol of CT-first triage and active telemedicine methods by a selected team tackling COVID-19: An experimental research study. J Infect Public Health,14(9):1212-1217.2021.
  11. Miyake S,Higurashi T,Jono T,Akimoto T,Ogawa F,Oi Y,Tanaka K,Hara Y,Kobayashi N,Kato H,Yamashiro T,Utsunomiya D,Nakajima A,Yamamoto T,Maeda S,Kaneko T,Takeuchi I. Real-world evaluation of a computed tomography-first triage strategy for suspected Coronavirus disease 2019 in outpatients in Japan: An observational cohort study. Medicine (Baltimore),100(22):e26161.2021.
  12. Ohya T,Nakagawa K,Arai Y,Kato H. Visualisation of droplets produced by dental air turbines that require infection control measured during coronavirus-2019 outbreaks. J Hosp Infect,S0195-6701(21)00354-6.2021.
  13. Sakamoto Y,Kawabe K,Suzuki T,Sano K,Ide K,Nishigaki T,Enoki Y,Taguchi K,Koike H,Kato H,Sahashi Y,Matsumoto K. Species Distribution of Candidemia and Their Susceptibility in a Single Japanese University Hospital: Prior Micafungin Use Affects the Appearance of Candida parapsilosis and Elevation of Micafungin MICs in Non-parapsilosis Candida Species. Journal of Fungi,7(8):596.2021.
  14. Samukawa S,Yoshimi R,Kirino Y,Nakajima H.: The PRY/SPRY domain of pyrin/TRIM20 interacts with β 2-microglobulin to promote inflammasome formation. Sci Rep,11(1):23613,2021
  15. Yamayoshi S,Yasuhara A,Ito M,Akasaka O,Nakamura M,Nakachi I,Koga M,Mitamura K,Yagi K,Maeda K,Kato H,Nojima M,Pattinson D,Ogura T,Baba R,Fujita K,Nagai H,Yamamoto S,Saito M,Adachi E,Ochi J,Hattori SI,Suzuki T,Miyazato Y,Chiba S,Okuda M,Murakami J,Hamabata T,Iwatsuki-Horimoto K,Nakajima H,Mitsuya H,Omagari N,Sugaya N,Yotsuyanagi H,Kawaoka Y. Antibody titers against SARS-CoV-2 decline,but do not disappear for several months. EClinicalMedicine,32:100734.2021.
  16. 王華帆,乙竹泰,鈴木華織,加藤英明,山川有子,山口由衣:ばら疹,頭頂部脱毛,全身の関節痛から診断に至った第2期梅毒.皮膚病診療,43(10):944–947.2021.

総説

  1. 井出恵子,加藤英明,菱本明豊.「COVID-19 ICUにおけるパンデミック対策」医療従事者や患者・患者家族のメンタルヘルスを守る要点.INTENSIVIST,2021.
  2. 加藤英明.「腎疾患治療薬update」ウイルス治療薬.腎と透析,91:470-475.2021.
  3. 加藤英明,坂本史衣,瀬尾龍太郎,林淑朗,牧野淳.「COVID-19 ICUにおけるパンデミック対策座談会」with コロナとコロナ後の世界.INTENSIVIST,3:594-601.2021
  4. 加藤英明.「感染症と消化器」カンジダ感染症.臨牀消化器内科.36(3):303–309.2021.

検索 ページトップへ